{"organizations": [], "uuid": "44106c0241f46d6640f67c61d19eca3f7b9d12e1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/16/business-wire-bioqual-presents-financial-results-for-third-quarter-of-fiscal-year-2018.html", "country": "US", "domain_rank": 767, "title": "BIOQUAL Presents Financial Results for Third Quarter of Fiscal Year 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-16T18:57:00.000+03:00", "replies_count": 0, "uuid": "44106c0241f46d6640f67c61d19eca3f7b9d12e1"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/16/business-wire-bioqual-presents-financial-results-for-third-quarter-of-fiscal-year-2018.html", "ord_in_thread": 0, "title": "BIOQUAL Presents Financial Results for Third Quarter of Fiscal Year 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "md.", "sentiment": "none"}, {"name": "bioqual", "sentiment": "none"}, {"name": "rockville", "sentiment": "none"}], "organizations": [{"name": "news service", "sentiment": "none"}, {"name": "bioqual", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL, Inc. (OTC Pink: BIOQ) ( www.bioqual.com ):\nNine Months Ended Three Months Ended February 28, February 28, February 28, February 28, 2018 2017 2018 2017 Revenue $ 26,132,351 $ 27,716,798 $ 8,331,395 $ 9,068,275 Income Before Income Tax $ 3,824,580 $ 4,949,235 1,202,918 1,459,486 Net Income $ 2,312,980 $ 2,858,135 799,018 842,786 Basic Earnings per Share of Common Stock\n$\n2.59\n$\n3.20\n.89\n.94\nDiluted Earnings per Share of Common Stock\n$\n2.59\n$\n3.20\n.89\n.94\nWeighted Average Number of Shares Outstanding For Basic Earnings\n893,932\n893,416\n894,416\n893,416\nWeighted Average Number of Shares Outstanding For Diluted Earnings\n893,932\n893,416\n894,416\n893,416\nSubsequent Development\nIn April 2018, the Company subscribed to the OTC Disclosure and News Service and now discloses quarterly and annual financial and other corporate information to the OTC Pink Marketplace. The information disclosure meets the OTC requirements necessary to reclassify BIOQUAL’s listing from the “No Information” category to the “Current Information” category. Although the Company will continue its historic practice of disclosing its financial results on its website, the information reported to the OTC will provide additional information required by the OTC. The annual subscription cost for this service is $5,000.\nFor more detail related to the fiscal year 2018 third quarter results, please visit our web site at www.bioqual.com and OTCMarkets.com/stock/BIOQ/disclosure .\nStatements herein that are not descriptions of historical facts are forward-looking and subject to risk and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts and obtain new contracts; the Company’s ability to obtain new commercial contracts; the performance of the business acquired in the ABL acquisition; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual cost incurred in performing its contracts and the Company’s ability to manage its costs; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180416005902/en/\nBIOQUAL, Inc.\nMark G. Lewis, Ph.D., CEO, 240-404-7654\nSource: BIOQUAL, Inc.", "external_links": ["http://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.otcmarkets.com%2Fstock%2FBIOQ%2Fdisclosure&esheet=51789333&newsitemid=20180416005902&lan=en-US&anchor=OTCMarkets.com%2Fstock%2FBIOQ%2Fdisclosure&index=3&md5=96f508870fd21129225d49862f01c7c6", "https://www.businesswire.com/news/home/20180416005902/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.bioqual.com&esheet=51789333&newsitemid=20180416005902&lan=en-US&anchor=www.bioqual.com&index=2&md5=98137620812fd6d11ab05782176675d9", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.bioqual.com&esheet=51789333&newsitemid=20180416005902&lan=en-US&anchor=www.bioqual.com&index=1&md5=cece54ab4a6842d8a7669514e52508a6"], "published": "2018-04-16T18:57:00.000+03:00", "crawled": "2018-04-16T21:08:38.020+03:00", "highlightTitle": ""}